Qube Research & Technologies (QRT)
TCON

Qube Research & Technologies (QRT)’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40
Closed -$140 – 4979
2023
Q4 		$140 Buy
+40
New +$141 ﹤0.01% 4001

Other funds holding TCON

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TCON Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2024, closing a stake of 40 shares — an estimated $140 sold.

Qube Research & Technologies (QRT) first reported a position in TCON in Q4 2023 and held it in 1 quarter. The position peaked at $140 in Q4 2023. 29 funds tracked by Wall St. Rank hold TCON as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 40 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $140.
  • Qube Research & Technologies (QRT) first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s TRACON Pharmaceuticals, Inc. Common Stock position peaked at $140 in Q4 2023.
  • 29 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.